Alpha 2.0
Login Register
» Articles » PMID: 36609524

The New 2022 Pulmonary Hypertension Guidelines: Some Small Steps and Some Giant Leaps Forward for Evidence-based Care

Overview
Journal Eur Respir J
Specialty Pulmonary Medicine
Date 2023 Jan 7
PMID 36609524
Authors
Laura C Price
Jason Weatherald
Affiliations
Soon will be listed here.
Citing Articles

Sarcoidosis-Associated Pulmonary Hypertension.

Israel-Biet D, Pastre J, Nunes H J Clin Med. 2024; 13(7).

PMID: 38610818 PMC: 11012707. DOI: 10.3390/jcm13072054.

International trends in pulmonary hypertension mortality between 2001 and 2019: Retrospective analysis of the WHO mortality database.

Lin P, Jiang F, Li X, Zhao Y, Shi Y, Liang Z Heliyon. 2024; 10(4):e26139.

PMID: 38384545 PMC: 10879023. DOI: 10.1016/j.heliyon.2024.e26139.

Role of micro-RNAs 21, 124 and other novel biomarkers in distinguishing between group 1 WHO pulmonary hypertension and group 2, 3 WHO pulmonary hypertension.

Dimitry M, Soliman Y, Elkorashy R, Raslan H, Kamel S, Hassan E Egypt Heart J. 2023; 75(1):76.

PMID: 37646902 PMC: 10468479. DOI: 10.1186/s43044-023-00395-w.